文献速递运动医学关节外科

3829例患者半月板修复结局的荟萃分析:最短随访2至5年的总体失败率及影响因素

Meniscal Repair Outcome in 3829 Patients With a Minimum Follow-up From 2 Years Up to 5 Years: A Meta-analysis on the Overall Failure Rate and Factors Influencing Failure.
PubMed 文献 · Am J Sports Med · 2023-04-06

该荟萃分析纳入51项研究、3931个半月板,最短随访24个月,总体失败率为14.8%。合并前交叉韧带重建的半月板修复失败率显著低于无前交叉韧带损伤的膝关节(8.5% vs 14%;P=0.043),外侧半月板修复失败率显著低于内侧(6.1% vs 10.8%;P=0.031),全内技术与由内向外技术失败率无显著差异(11.9% vs 10.6%;P>0.05)。

要点

  • 半月板修复总体失败率为14.8%,最短随访24个月。
  • 合并前交叉韧带重建者失败率8.5%,显著低于无前交叉韧带损伤者的14%(P=0.043)。
  • 外侧半月板修复失败率6.1%,显著低于内侧的10.8%(P=0.031)。

核心结论

  • 该荟萃分析纳入近4000例患者,最短随访2至5年,半月板修复总体失败率为14.8%。
  • 半月板修复仍是失败率较高的手术,尤其在术后前2年内。
  • 合并前交叉韧带重建或外侧半月板修复与较好结局相关。
  • 采用最新一代器械的全内半月板修复失败率低于10%。
  • 失败机制和失败时间记录不足,需进一步研究以更好理解再撕裂机制。

研究设计与样本

  • 系统综述与荟萃分析,证据等级4级。
  • 检索PubMed和Scopus,纳入2000年1月至2021年11月发表、最短随访24个月的半月板修复结局研究。
  • 初检识别6519项研究,最终51项研究符合纳入标准。
  • 共纳入3931个半月板,平均随访43个月。
  • 采用随机效应模型合并失败率,并以比值比及95%CI形式估计效应量。

主要发现

  • 总体合并失败率为14.8%。
  • 合并前交叉韧带重建的半月板修复失败率为8.5%,无任何前交叉韧带损伤报告的膝关节为14%,前者显著低于后者(P=0.043)。
  • 外侧半月板修复合并失败率为6.1%,内侧半月板修复为10.8%,外侧显著低于内侧(P=0.031)。
  • 全内修复与由内向外修复的合并失败率分别为11.9%与10.6%,两者无显著差异(P>0.05)。
  • 采用最新一代器械的全内半月板修复失败率低于10%。

关键数值与推荐

  • 纳入标准:报道半月板修复结局且最短随访24个月的研究。
  • 总体合并失败率为14.8%。
  • 合并前交叉韧带重建者失败率8.5% vs 无前交叉韧带损伤报告者14%(P=0.043)。
  • 外侧半月板修复失败率6.1% vs 内侧10.8%(P=0.031)。
  • 全内修复失败率11.9% vs 由内向外10.6%(P>0.05)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 失败机制和失败时间记录不足。
  • 需进一步研究以更好理解再撕裂机制。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The importance of meniscal repair is widely accepted because of the association of loss of meniscal tissue with the development of early-onset knee arthritis. Many factors influencing the results of meniscal repair have been reported, but results remain controversial. PURPOSE: This meta-analysis determines the pooled meniscal repair failure rate of studies with a minimum follow-up of 2 years up to 5 years, with a mean follow-up of 43 months. Moreover, selected failure-influencing factors are analyzed. STUDY DESIGN: Systematic review and meta-analysis; Level of evidence, 4. METHODS: PubMed and Scopus were searched for studies published between January 2000 and November 2021 reporting on meniscal repair outcome with a minimum follow-up of 24 months. The overall pooled failure rate and pooled failure rates for possible predictors were calculated. Random-effect models were used to pool failure rates, and effect estimates in the form of odds ratios with 95% CIs were established. RESULTS: The initial literature search identified 6519 studies. A total of 51 studies met the inclusion criteria. In total, 3931 menisci were included with an overall failure rate of 14.8%. Subgroup analysis revealed a significantly lower failure rate for meniscal repair with concomitant anterior cruciate ligament (ACL) reconstruction compared with knees without any reported injury to the ACL (8.5% vs 14%; P = .043). The pooled failure rate for lateral meniscal repair was significantly lower than that for medial meniscal repair (6.1% vs 10.8%; P = .031). Pooled failure rates of all-inside and inside-out repair were not significantly different (11.9% vs 10.6%; P > .05). CONCLUSION: This meta-analysis on close to 4000 patients demonstrates an overall meniscal repair failure rate of 14.8% at a minimum follow-up from 2 years up to 5 years. Meniscal repair remains a procedure with a high failure rate, especially within the first 2 postoperative years. This review and meta-analysis also identified clinically relevant factors associated with favorable outcomes such as concomitant ACL reconstruction or repair of the lateral meniscus. All-inside meniscal repair with the latest-generation devices yields failure rates of <10%. The failure mechanism and the time of failure is poorly documented; further studies are needed for a better understanding of the retear mechanism.

来源:Am J Sports Med,查看原文。版权归原作者所有。

引用

  1. Schweizer C, Hanreich C, Tscholl PM, et al. Meniscal Repair Outcome in 3829 Patients With a Minimum Follow-up From 2 Years Up to 5 Years: A Meta-analysis on the Overall Failure Rate and Factors Influencing Failure. Am J Sports Med. 2023. PMID: 37022676. doi:10.1177/03635465231158385

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。